NCT07434908 Heparin-binding Protein and Lungedema in ICU Patients.
| NCT ID | NCT07434908 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Umeå University |
| Condition | Lung Edema |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2024-05-06 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2024-05-06 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this single center observational cohort study is to investigate the relationship between physiological measures of lung oedema, and the biomarker Heparin-binding Protein (HBP). The main questions it aims to answer are: * Does the concentration of HBP in plasma correlate with measures of lung vascular permeability and extravascular water in the lungs? * Does the concentration of HBP in plasma correlate with the patient's total accumulated fluid balance? Researchers will collect blood samples and gather information on lung vascular permeability and extravascular lung water in Intensive care patients who are provided with a hemodynamic surveillance system called PiCCO. The study will include 25 patients.
Eligibility Criteria
Inclusion Criteria: * Patients \>18 years * Monitored with a PiCCO system Exclusion Criteria: • Patients transferred from another ICU
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07434908 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Edema. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07434908 currently recruiting?
Yes, NCT07434908 is actively recruiting participants. Contact the research team at line.samuelsson@regionjh.se for enrollment information.
Where is the NCT07434908 trial being conducted?
This trial is being conducted at Östersund, Sweden.
Who is sponsoring the NCT07434908 clinical trial?
NCT07434908 is sponsored by Umeå University. The trial plans to enroll 25 participants.